Pérez-Elizondo AD

Language: Spanish
References: 9
Page: 96-98
PDF size: 139.67 Kb.

ABSTRACT

Diffuse neonatal hemangiomatosis is a rare entity and is a serious disorder in which multiple cutaneous and visceral hemangiomas are widely distributed and sometimes may be fatal. Complications include heart failure, bleeding, and liver failure, among others. Treatment is aimed at avoiding adverse effects and complications.

REFERENCES

1. Ollague J, Hemangiomatosis neonatal difusa, Folia Dermatol Peru. 2007; 18: 28-31.

2. Metry DW, Hebert AA, Benign cutaneous vascular tumors of infancy: when to worry, what to do, Arch Dermatol, 2000; 136: 905-914.

3. Ohnishi S, Miyagishima T, Nakagawa M, Kamata T, Kishimoto A, Choi GH et al, Diffuse neonatal hemangiomatosis without cutaneous lesions in an adult-a case report, Angiology, 2002; 53: 235-237.

4. Mulliken JB, Glowacki J, Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics, Plast Reconstr Surg, 1982; 69: 412-422.

5. Wananukul S, Voramethkul W, Nuchprayoon I, Seksarn P, Diffuse neonatal hemangiomatosis: report of 5 cases, J Med Assoc Thai, 2006; 89: 1297-1303.

6. Gottschling S, Schneider G, Meyer S, Reinhard H, Dill-Mueller D, Graf N, Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide, Pediatr Blood Cancer, 2006; 46: 239-242.

7. Enjolras O, Brevière GM, Roger G, Tovi M, Pellegrino B, Varotti E et al, Vincristine treatment for function –and life– threatening infantile hemangioma, Arch Pediatr, 2004; 11: 99-107.

8. Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, Ammour A, Broue P, Vial J et al, Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis, J Pediatr, 2010; 157: 340-342.

9. Vlahovic A, Simic R, Djokic D, Ceran C, Diffuse neonatal hemangiomatosis treatment with cyclophosphamide: a case report, J Pediatr Hematol Oncol, 2009; 31: 858-860.